EU and US could reach trade deal this weekend - Reuters
Vincent Roche, the Chair and CEO of Analog Devices Inc. (NASDAQ:ADI), a prominent semiconductor company with a market capitalization of $111.2 billion and a GOOD financial health score according to InvestingPro, recently executed a series of stock transactions. The company, currently trading at a high P/E ratio of 71.9, has demonstrated strong financial stability with 22 consecutive years of dividend increases. On February 26, 2025, Roche sold 10,000 shares of Analog Devices’ common stock at a price of $234.82 per share, totaling approximately $2.35 million. This transaction was carried out under a pre-established 10b5-1 trading plan. With 19 analysts recently revising earnings upward and a consensus price target suggesting potential upside, this insider activity provides valuable context for investors. For comprehensive insider trading analysis and additional ProTips, explore InvestingPro’s detailed research reports.
In addition to the stock sale, Roche exercised options to acquire 10,000 shares at $91.13 per share, representing a total transaction value of $911,300. Following these transactions, Roche holds 21,982.973 shares directly. Furthermore, additional shares are held indirectly through trusts, including the Vincent Roche 2023 and 2024 Grantor Retained Annuity Trusts.
In other recent news, Analog Devices reported earnings per share (EPS) of $1.63 for the January quarter, surpassing the consensus estimate of $1.54, despite a 4% decline in sales. The sales dip was attributed to lower performance in the industrials, automotive, and communications segments, though the consumer segment saw a 19% increase. UBS raised its price target for Analog Devices to $300, maintaining a Buy rating, citing improved industrial sector indicators and robust order strength. CFRA also increased its price target to $265, highlighting positive trends in bookings and a rebound in orders. Benchmark adjusted its price target to $275, emphasizing the company’s quarter-over-quarter growth in all B2B markets except the Consumer segment. Truist Securities raised its target to $248 but maintained a Hold rating, expressing concerns over valuation despite optimistic projections. Morgan Stanley (NYSE:MS) increased its price target to $250, maintaining an Overweight rating, noting the company’s strong financial performance and position as a stable investment amid macroeconomic uncertainty.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.